AlphaMark Advisors’s Diversified Healthcare Trust DHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,400
Closed -$3K 696
2022
Q2
$3K Hold
1,400
﹤0.01% 503
2022
Q1
$4K Hold
1,400
﹤0.01% 493
2021
Q4
$4K Hold
1,400
﹤0.01% 470
2021
Q3
$5K Sell
1,400
-2,200
-61% -$8.3K ﹤0.01% 458
2021
Q2
$15K Hold
3,600
0.01% 358
2021
Q1
$17K Sell
3,600
-500
-12% -$2.3K 0.01% 346
2020
Q4
$17K Sell
4,100
-4,900
-54% -$19.3K 0.01% 313
2020
Q3
$32K Hold
9,000
0.01% 237
2020
Q2
$40K Hold
9,000
0.02% 218
2020
Q1
$33K Hold
9,000
0.02% 211
2019
Q4
$76K Hold
9,000
0.03% 173
2019
Q3
$83K Hold
9,000
0.04% 169
2019
Q2
$74K Sell
9,000
-700
-7% -$5.83K 0.03% 175
2019
Q1
$114K Hold
9,700
0.05% 136
2018
Q4
$114K Hold
9,700
0.05% 124
2018
Q3
$170K Hold
9,700
0.07% 136
2018
Q2
$175K Hold
9,700
0.07% 134
2018
Q1
$152K Sell
9,700
-1,600
-14% -$26.6K 0.06% 133
2017
Q4
$216K Sell
11,300
-3,650
-24% -$69.9K 0.08% 116
2017
Q3
$292K Hold
14,950
0.12% 95
2017
Q2
$306K Buy
+14,950
New +$319K 0.13% 91

Other funds holding DHC

AlphaMark Advisors's DHC Position: Q3 2022 in Review

AlphaMark Advisors sold out of Diversified Healthcare Trust (DHC) in Q3 2022, closing a stake of 1,400 shares — an estimated $3K sold.

AlphaMark Advisors first reported a position in DHC in Q2 2017 and held it in 21 quarters. The position peaked at $306K in Q2 2017. 219 funds tracked by Wall St. Rank hold DHC as of Q3 2022.

  • AlphaMark Advisors reported no remaining Diversified Healthcare Trust position as of Q3 2022 after selling out during the quarter.
  • AlphaMark Advisors sold 1,400 Diversified Healthcare Trust shares in Q3 2022, an estimated $3K.
  • AlphaMark Advisors first reported a position in Diversified Healthcare Trust in Q2 2017 and held it in 21 quarters.
  • AlphaMark Advisors's Diversified Healthcare Trust position peaked at $306K in Q2 2017.
  • 219 funds tracked by Wall St. Rank held Diversified Healthcare Trust as of Q3 2022.

Based on AlphaMark Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.